Published: Sep 18th, 2013
The University of Florida today launched the Southeast Center for Integrated Metabolomics with a five-year, $9 million grant from the National Institutes of Health to help chart the course of biomedical discovery in the emerging field of metabolomics.
Published: Sep 17th, 2013
Topic BIG DATA Processing Date Thursday, November 7, 2013 Schedule View Agenda Location The location for Fall 2013 RC Day is the Clinical and Translational Research Building (CTRB). RC Day […]
Published: Sep 17th, 2013
What: Research Computing Training When: Thursday, September 19th at 12:50 Where: NPB, Room 2205 Topic: Galaxy Overview, The Basics This session will focus on Galaxy, a web-based application platform with […]
Published: Sep 13th, 2013
SECIM is developing the capacity to offer Isotopic Ratio Outlier Analysis (IROA) to scientists through a partnership with IROA Technologies.
Published: Sep 13th, 2013
Working with the National High Magnetic Field Lab and Agilent Technologies, SECIM developed a new NMR probe that is among the most sensitive NMR equipment in the world.
The Metabolomics Consortium Coordinating Center together with the Southeast Center for Integrated Metabolomics requests applications for up to 12-month pilot projects.
Monday, Jan. 27. Advances in gas-phase separations for multi-omics analysis, by Yehia M. Ibrahim, Scientist, Biological Sciences Division, Pacific Northwest National Laboratory
SECIM and the Metabolomics Consortium Coordinating Center (M3C) proudly present Metabolomics Winter School. This course is best suited for graduate students, postdocs, researchers and faculty interested in metabolomics for their […]
Compound identification is the most critical step in metabolomics and exposome research. While recent years have brought improvements in informatics tools, in-silico databases and experimental mass spectral libraries, there are […]
We provide metabolomic profiling to the entire UF community and have built a library that enables metabolite detection in a variety of sample types.